Crosslinked polysaccharide beads and their biomedical uses
View Patent ↗The present inventions relates to beads as biocompatible material adapted for use within the human or animal body. Said beads are highly useful for tissue engineering, in situ tissue regeneration, as well as for drug and/or cells delivery. In addition, said beads may support biotechnological applications such as cell carriers.
1. A method for preparing beads comprising the following steps:
a) preparing an alkaline aqueous solution comprising at least one polysaccharide and a cross linking agent;
b) dispersing said alkaline aqueous solution into an hydrophobic phase in order to obtain a water-in-oil (w/o) emulsion;
c) transforming the w/o emulsion into beads by placing said w/o emulsion at a temperature from about 4° C. to about 80° C. for a sufficient time to allow the cross-linking of said at least one polysaccharide;
d) submerging said beads into an aqueous solution; and
e) washing said beads; wherein,
said polysaccharide is selected from the group consisting of dextran, pullulan, agar, alginic acid, starch, hyaluronic acid, inulin, heparin, fucoidan, chitosan and mixtures thereof; and
step b) is performed in the absence of surfactant.
2. The method of claim 1 , wherein said polysaccharide is a mixture of pullulan/dextran in a ratio of 75:25 w/w.
3. The method according to claim 1 , wherein said cross-linking agent is selected from the group consisting of trisodium trimetaphosphate (STMP), phosphorus oxychloride (POCl 3 ), epichlorohydrin, formaldehydes, carbodiimides, and glutaraldehydes.
4. The method according to claim 1 , wherein said hydrophobic phase is a vegetable oil.
5. The method of claim 4 , wherein said vegetable oil is selected from the group consisting of canola oil, corn oil, cottonseed oil, safflower oil, soybean oil, extra virgin olive oil, sunflower oil, palm oil, medium-chain triglycerides (MCT) oil, and trioleic oil.
6. The method according claim 1 , wherein the alkaline aqueous solution further comprises a porogen agent.
7. The method according to claim 6 , wherein the porogen agent is selected from the group consisting of sodium chloride, calcium chloride, ammonium carbonate, ammonium bicarbonate, calcium carbonate, sodium carbonate, sodium bicarbonate and mixtures thereof.
8. The method according to claim 1 , wherein the alkaline aqueous solution further comprises hydroxyapatite.
9. The method of claim 8 , wherein said hydroxyapatite is nano-hydroxyapatite.
10. The method according to claim 1 , wherein the alkaline aqueous solution further comprises a drug.
11. The method according to claim 1 , wherein said bead has a mean diameter of more than about 10 μm.